Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Skin microbiome and dermatologic disorders
Tiffany C. Scharschmidt, Julia A. Segre
Tiffany C. Scharschmidt, Julia A. Segre
Published February 3, 2025
Citation Information: J Clin Invest. 2025;135(3):e184315. https://doi.org/10.1172/JCI184315.
View: Text | PDF
Review Series

Skin microbiome and dermatologic disorders

  • Text
  • PDF
Abstract

Human skin acts as a physical barrier to prevent the entry of pathogenic microbes while simultaneously providing a home for commensal bacteria and fungi. Microbiome sequencing studies have demonstrated the unappreciated diversity and selectivity of these microbes. Functional studies have demonstrated the impact of specific strains to tune the immune system, sculpt the microbial community, provide colonization resistance, and promote epidermal barrier integrity. Recent studies have integrated the microbiome, immunity, and tissue integrity to understand their interplay in common disorders such as atopic dermatitis. In this Review, we explore microbiome shifts associated with cutaneous disorders with an eye toward how the microbiome can be mined to identify new therapeutic opportunities.

Authors

Tiffany C. Scharschmidt, Julia A. Segre

×

Figure 3

Commensal tuning of cutaneous immune function.

Options: View larger image (or click on image) Download as PowerPoint
Commensal tuning of cutaneous immune function.
Commensal microbes stimul...
Commensal microbes stimulate production of antimicrobial peptides (AMPs) by keratinocytes, sebocytes, sweat glands, and granulocytes, amplifying the innate immune defense of skin against potential pathogens. Specific microbial products also have the ability to expand certain skin lymphocyte populations. For example, riboflavin derivatives made by various bacteria are recognized by skin MAIT cells leading to their expansion and activation in the tissue. Similarly, fmet peptide produced by a particular clade of S. epidermidis is presented by nonclassical MHC-I molecules and leads to expansion of IL-17–producing CD8+ T cells (Tc17). DCs play a role both in initial uptake of skin bacteria and presentation of commensal antigens to naive T cells in the skin-draining lymph node as well as restimulation and cytokine production by commensal-specific skin-resident T cells. Type 2 DCs are especially capable of commensal uptake, at least for S. epidermidis, as shown in human and murine skin. In the early life window, these DC2 also play a key role in preferentially generating commensal-specific Tregs versus conventional T cells, usually Th17 cells. Commensal-specific Th17, however, also plays a key role in immune defense as well as homeostatic functions such as reepithelialization after barrier breach.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts